secwatch.observer — SEC 8-K summary
======================================

Issuer:     CareDx, Inc. (CDNA)
CIK:        0001217234
Form:       8-K/A
Filed at:   2026-02-25T23:59:59+00:00
Accession:  0001217234-26-000019
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01, 5.02, 7.01
LLM model:  deepseek-v4-flash:cloud@v2

CareDx Q4 rev $108M +25% YoY, FY25 rev $380M; FY26 guide $420-444M; CFO resigns, Kennedy appointed
--------------------------------------------------------------------------------

- Q4 revenue $108M (+25% YoY); full-year revenue $380M (+14%). FY2026 guidance $420-444M.
- Q4 GAAP net loss $4M vs $88M income (prior year had $96M litigation reversal); FY25 GAAP loss $21M; adj. EBITDA $32M.
- Testing services Q4 rev $78M (+23%), volume ~53K tests (+17%); full-year rev $275M.
- CFO Nathan Smith resigns for personal reasons; Keith Kennedy (COO since Sept 2024) appointed CFO & COO effective Feb 26.
- Smith separation: 9 months base salary, $91,643 bonus, COBRA reimbursement, and 5,840 RSUs vesting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1217234/000121723426000019/0001217234-26-000019-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1217234/000121723426000019/cdna-20260224.htm
  HTML page:      https://secwatch.observer/filing/0001217234-26-000019

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer